Physician
Cardiology
Dr. Udho Thadani, MD
|
|
Give Review
Udho Thadani is an expert in the field of Cardiology. He has 1 awards "Fellow (FACC)". Udho Thadani is also published. He has 100 publications published. The lastest publication: "Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy.'
Publications
- Challenges with Nitrate Therapy and Nitrate Tolerance: Prevalence, Prevention, and Clinical Relevance.
- Pigment Epithelial-Derived Factor and Acute Coronary Syndrome: A Novel Protective Biomarker but Not for Routine Clinical Use at Present.
- Retroperitoneal Hemorrhage after Cardiac Catheterization and Percutaneous Coronary Interventions.
- Obesity, brain natriuretic Peptide levels and mortality in patients hospitalized with Heart failure and preserved left ventricular systolic function.
- Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable Angina or for those with refractory Angina pectoris...
- Is Risk Factor Control and Guideline-Based Medical Therapy Optimal in Patients with Nonobstructive Coronary Artery Disease? A Veterans Affairs Study.
- Osteoprotegerin and ST Segment Myocardial Infarction: A Novel Risk Marker but Not for Routine Use at Present.
- Use of hydralazine-isosorbide dinitrate combination in african american and other race/ethnic group patients with Heart failure and reduced left ventricular ejection f...
- Long-term follow-up of participants with Heart failure in the antihypertensive and lipid-lowering treatment to prevent Heart attack trial (ALLHAT).
- The Benefit of Cardiac Resynchronization Therapy and QRS Duration: A Meta-Analysis.
- Exercise performance, physical activity, and health-related quality of life in participants with stable Angina.
- Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
- Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic Heart failure due to severe left ventricular systolic dysfunction.
- Evidence for using clopidogrel alone or in addition to aspirin in post Coronary artery bypass surgery patients.
- Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes.
- Isosorbide dinitrate/hydralazine: its role in the treatment of Heart failure.
- Metabolic and clinical outcomes in nondiabetic individuals with the metabolic Syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for h...
- Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable Angina and acute myocardial infarction.
- Side effects of using nitrates to treat Angina.
- Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive ...
- Selection of optimal therapy for chronic stable Angina.
- Efficacy and safety of fasudil in patients with stable Angina: a double-blind, placebo-controlled, phase 2 trial.
- Can nicorandil treat Angina pectoris effectively?
- Therapy of stable Angina pectoris: the uncomplicated patient.
- Modified-release formulation of trimetazidine for exceptional control of Angina pectoris: fact or fiction.
- Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Trea...
- Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable Angina: yet another failed strategy to prevent tolerance.
- Current medical management of chronic stable Angina.
- Recurrent and refractory Angina following revascularization procedures in patients with stable Angina pectoris.
- Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
- Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable Angina.
- Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable Angina pectoris.
- The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exer...
- Selective L-type, T-type, and nonspecific calcium-channel blockers for stable Angina pectoris.
- Comparison of pharmacokinetics of lanoteplase and alteplase during Acute myocardial infarction.
- Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in Heart failure.
- Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, Angina, and heart failure.
- Treatment of stable Angina.
- Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy.
- Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase...
- Choosing the most appropriate treatment for stable Angina. Safety considerations.
- FDA Panel report: January 1998.
- Severe symptomatic sinus bradycardia associated with mesalamine use.
- Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel.
- Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable Angina pectoris. D...
- Effect of 17-beta estradiol in the rabbit: endothelium-dependent and -independent mechanisms of vascular relaxation.
- Lack of arrhythmogenicity with ST-segment elevation during high-dose of dobutamine atropine stress in patients with documented or suspected Coronary artery disease.
- Management of patients with chronic stable Angina at low risk for serious cardiac events.
- Oral nitrates: more than symptomatic therapy in Coronary artery disease?
- Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable Angina pectoris. Zatebradine Investigators.
- Additional antiAnginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable Angina pectoris.
- Nitrate tolerance, rebound, and their clinical relevance in stable Angina pectoris, unstable Angina, and heart failure.
- Secondary preventive potential of nitrates in ischaemic heart Disease.
- Ricin disturbs calcium homeostasis in the rabbit Heart.
- Hypertension and cardiovascular Disease risk in women.
- Ricin depresses cardiac function in the rabbit Heart.
- Myocardial infarct Artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wel...
- Nitrate therapy and the development of tolerance.
- Lack of pharmacologic tolerance and rebound Angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
- Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)
- Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable Angina pectoris. Ranolazine Study Group.
- Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable Angina pectoris. Diltiazem CD Study Group.
- Conversion from immediate-release to extended-release diltiazem in Angina pectoris.
- Duration of effects of isradipine during twice daily therapy in Angina pectoris.
- Mononitrates: defining the ideal long-acting nitrate.
- Nitrates for unstable Angina.
- Amlodipine in chronic stable Angina: results of a multicenter double-blind crossover trial.
- Ointments and transdermal nitroglycerin patches for stable Angina pectoris.
- Short and long-acting oral nitrates for stable Angina pectoris.
- Chronic stable Angina pectoris. Strategies for effective drug therapy.
- Oral isosorbide dinitrate in the treatment of Angina pectoris. Dose-response relationship and duration of action during acute therapy.
- Propranolol in Angina pectoris: comparison of therapy given two and four times daily.
- Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with Angina pectoris reproducible?
- Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with Angina pectoris.
- Kinetics of isosorbide dinitrate and relationships to pharmacological effects.
- Slow release oxprenolol in Angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
- Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.
- Influence of attenuation on radionuclide stroke volume determinations.
- Oral isosorbide dinitrate in Angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
- Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.
- SubAortic annular left ventricular aneurysm: an unusual cause of Aortic regurgitation.
- Nitrates for Angina pectoris. A critical review of therapeutic efficacy and tolerance.
- Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with Angina pectoris.
- Beta blockers in Hypertension.
- Beta adrenergic blocking agents for exertional Angina pectoris.
- Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in Angina pectoris.
- Pericarditis after Acute myocardial infarction.
- Profunda femoral arteriovenous fistula after percutaneous arterial and venous catheterization.
- Plasma cortisol, urinary 17-hydroxycorticoids, and urinary vanilyl mandelic acid after Acute myocardial infarction.
- Lignocaine therapy for ventricular ectopic activity after Acute myocardial infarction: a double-blind trial.
- Rheumatoid lung Disease with pulmonary fibrosis necrobiotic nodules and pleural effusion.
- Proceedings: Left ventricular pressure-volume changes during exercise-induced pain in patients with Angina pectoris.
- Cardiovascular effects of weight reduction in obese patients with Angina pectoris.
- Comparison of adrenergic beta-receptor antagonists in Angina pectoris.
- Anti-Anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in Angina pectoris.
- Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable Angina pectoris.
- Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for Angina pectoris.
- Doppler echocardiographic profiles in obstructive right and left Atrial myxomas.
- Atenolol for ventricular ectopy: a dose-response study.
Schools
AllIndia Institute of Medical Science Ansari Nagar
All India Institute Med Science
Kingston Genl Hosphull And Royal Infirm
Kingston Genl Hosphull And Royal Infirmleeds
QueenS University
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomegaly
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Helpful Reviews
Similar Doctors
|
|
Dr. Niraj K. Prasad, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Agha K. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Venkataraman Rajaram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chittur A. Sivaram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Purvi J. Parwani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ethan S. Munzinger, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Terrance Khastgir, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bryan D. Cogar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolyn R. Corn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael T. Hauser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl J. Rubenstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Can Hasdemir, MD |